ResMed (NYSE:RMD) : Traders are bullish on ResMed (NYSE:RMD) as it has outperformed the S&P 500 by a wide margin of 6.16% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.26%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.54% in the last 1 week, and is up 7.88% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have rallied 12.39% from its 1 Year high price. On Jul 8, 2016, the shares registered one year high at $64.57 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $60.36 and the 200 Day Moving Average price is recorded at $57.83.
The stock has recorded a 20-day Moving Average of 5.5% and the 50-Day Moving Average is 9.35%.
ResMed (NYSE:RMD): stock turned positive on Friday. Though the stock opened at $63.79, the bulls momentum made the stock top out at $64.57 level for the day. The stock recorded a low of $63.535 and closed the trading day at $64.51, in the green by 1.83%. The total traded volume for the day was 1,356,179. The stock had closed at $63.35 in the previous days trading.
In an insider trading activity, The director, of Resmed Inc, Farrell Peter C had unloaded 20,000 shares at $63.62 per share in a transaction on July 7, 2016. The total value of transaction was $1,272,400. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.